| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13168* | 2021 |
| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 485 | 2023 |
| Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation M Rahmani, EM Davis, C Bauer, P Dent, S Grant Journal of biological chemistry 280 (42), 35217-35227, 2005 | 353 | 2005 |
| The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571 C Yu, M Rahmani, D Conrad, M Subler, P Dent, S Grant Blood 102 (10), 3765-3774, 2003 | 334 | 2003 |
| A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia SW Paugh, BS Paugh, M Rahmani, D Kapitonov, JA Almenara, T Kordula, ... Blood, The Journal of the American Society of Hematology 112 (4), 1382-1391, 2008 | 314 | 2008 |
| Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-κB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative … Y Dai, M Rahmani, P Dent, S Grant Molecular and cellular biology 25 (13), 5429-5444, 2005 | 312 | 2005 |
| A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2 Y Dai, M Rahmani, SJ Corey, P Dent, S Grant Journal of Biological Chemistry 279 (33), 34227-34239, 2004 | 309 | 2004 |
| The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress M Rahmani, EM Davis, TR Crabtree, JR Habibi, TK Nguyen, P Dent, ... Molecular and cellular biology 27 (15), 5499-5513, 2007 | 281 | 2007 |
| Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce … C Yu, G Krystal, L Varticovksi, R McKinstry, M Rahmani, P Dent, S Grant Cancer research 62 (1), 188-199, 2002 | 260 | 2002 |
| Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the … M Rahmani, E Reese, Y Dai, C Bauer, SG Payne, P Dent, S Spiegel, ... Cancer research 65 (6), 2422-2432, 2005 | 252 | 2005 |
| Targeting Mcl-1 for the therapy of cancer BA Quinn, R Dash, B Azab, S Sarkar, SK Das, S Kumar, RA Oyesanya, ... Expert opinion on investigational drugs 20 (10), 1397-1411, 2011 | 249 | 2011 |
| Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation MA Park, G Zhang, AP Martin, H Hamed, C Mitchell, PB Hylemon, M Graf, ... Cancer biology & therapy 7 (10), 1648-1662, 2008 | 204 | 2008 |
| Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and-resistant Bcr/Abl+ human myeloid leukemia cells C Yu, M Rahmani, J Almenara, M Subler, G Krystal, D Conrad, ... Cancer research 63 (9), 2118-2126, 2003 | 192 | 2003 |
| The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib C Yu, M Rahmani, P Dent, S Grant Experimental cell research 295 (2), 555-566, 2004 | 183 | 2004 |
| Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK-and NF-κB-dependent process Y Dai, M Rahmani, S Grant Oncogene 22 (46), 7108-7122, 2003 | 183 | 2003 |
| Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and … Y Dai, M Rahmani, XY Pei, P Dent, S Grant Blood 104 (2), 509-518, 2004 | 173 | 2004 |
| The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells SC Maggio, RR Rosato, LB Kramer, Y Dai, M Rahmani, DS Paik, ... Cancer research 64 (7), 2590-2600, 2004 | 169 | 2004 |
| Coadministration of the heat shock protein 90 antagonist 17-allylamino-17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces … M Rahmani, C Yu, Y Dai, E Reese, W Ahmed, P Dent, S Grant Cancer research 63 (23), 8420-8427, 2003 | 168 | 2003 |
| Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3-and Bim-dependent mechanism M Rahmani, MM Aust, E Attkisson, DC Williams Jr, A Ferreira-Gonzalez, ... Cancer research 73 (4), 1340-1351, 2013 | 166 | 2013 |
| 2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process N Gao, M Rahmani, P Dent, S Grant Oncogene 24 (23), 3797-3809, 2005 | 153 | 2005 |
